Preferred Label : dihydroquinghaosu, (3R-(3alpha,5abeta,6beta,8abeta,9alpha,10beta,12alpha,12aR*))-isomer;
UMLS semantic type : T109 - Organic Chemical;
CAS number : 81496-81-3;
Is substance : O;
UNII : X0UIV26ABX;
InChIKey : BJDCWCLMFKKGEE-KDTBHNEXSA-N;
Origin ID : M0321126;
UMLS CUI : C0956146;
ATC code(s)
- ATC code(s)
- CISMeF manual mappings
- Related record
- Semantic type(s)
- Validated automatic mappings to BTNT
https://www.has-sante.fr/portail/jcms/c_2962279/fr/eurartesim
2019
true
false
France
French
quinolines
artenimol
dihydroquinghaosu, (3R-(3alpha,5abeta,6beta,8abeta,9alpha,10beta,12alpha,12aR*))-isomer
dihydroquinghaosu, (3R-(3alpha,5abeta,6beta,8abeta,9alpha,10beta,12alpha,12aR*))-isomer
piperaquine
administration, oral
drug combinations
artenimol and piperaquine
antimalarials
malaria, falciparum
adult
child
infant
artemisinins
treatment outcome
risk management
evaluation of the transparency committee
artemisinins
---
http://www.has-sante.fr/portail/jcms/c_1726956/fr/eurartesim
http://www.has-sante.fr/portail/jcms/c_1221619/eurartesim
2014
false
France
French
french guiana
Cardiotoxicity
quinolines
quinolines
artenimol
artenimol
dihydroquinghaosu, (3R-(3alpha,5abeta,6beta,8abeta,9alpha,10beta,12alpha,12aR*))-isomer
dihydroquinghaosu, (3R-(3alpha,5abeta,6beta,8abeta,9alpha,10beta,12alpha,12aR*))-isomer
piperaquine
administration, oral
drug combinations
artenimol and piperaquine
antimalarials
malaria, falciparum
adult
child
infant
artemisinins
treatment outcome
controlled clinical trials as topic
antimalarials
artemisinins
piperaquine
risk management
long qt syndrome
pregnancy
product surveillance, postmarketing
evaluation of the transparency committee
---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=62434676
2013
France
summary of product characteristics
piperaquine
tablets
dihydroquinghaosu, (3R-(3alpha,5abeta,6beta,8abeta,9alpha,10beta,12alpha,12aR*))-isomer
piperaquine
---
http://www.has-sante.fr/portail/jcms/c_1251592/eurartesim-artenimol-/-piperaquine-antipaludique
2012
France
French
guidelines for drug use
evaluation of the transparency committee
Cardiotoxicity
malaria, falciparum
artenimol and piperaquine
drug combinations
piperaquine
piperaquine
dihydroquinghaosu, (3R-(3alpha,5abeta,6beta,8abeta,9alpha,10beta,12alpha,12aR*))-isomer
dihydroquinghaosu, (3R-(3alpha,5abeta,6beta,8abeta,9alpha,10beta,12alpha,12aR*))-isomer
artenimol
artenimol
antimalarials
antimalarials
adult
child
infant
long qt syndrome
aged
treatment outcome
clinical trials, phase iii as topic
quinolines
quinolines
artemisinins
artemisinins
comparative study
---
